Safety and Tolerability of Neladenoson Bialanate, a Novel Oral Partial Adenosine A1 Receptor Agonist, in Patients With Chronic Heart Failure

Adriaan Alexander Voors*, Hans Dirk Düngen, Michele Senni, Savina Nodari, Piergiuseppe Agostoni, Piotr Ponikowski, Jeroen J. Bax, Javed Butler, Raymond J. Kim, Bernard Dorhout, Wilfried Dinh, Mihai Gheorghiade

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and Tolerability of Neladenoson Bialanate, a Novel Oral Partial Adenosine A1 Receptor Agonist, in Patients With Chronic Heart Failure'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science